Discover other firms ranked in Corporate/M&A: Private Equity

4
Band 4
Goodwin
4
Goodwin
5 Years Ranked

View profile
Davis Polk & Wardwell LLP
4
Davis Polk & Wardwell LLP
10 Years Ranked

View profile
Linklaters
4
Linklaters
12 Years Ranked

View profile
5
Band 5
Morgan, Lewis & Bockius LLP
5
Morgan, Lewis & Bockius…
4 Years Ranked

View profile
A&O Shearman
5
A&O Shearman
25 Years Ranked

View profile
Hogan Lovells
5
Hogan Lovells
4 Years Ranked

View profile

Chambers Review

Provided by Chambers
Corporate/M&A: Private Equity - Asia-Pacific Region
5
Band 5
What the team is known for

Cleary Gottlieb has a streamlined team handling high-level private equity and public M&A around the region. An impressive workload includes representing leading Chinese corporates in a range of outbound acquisitions and advising major private equity houses on significant cross-border investments and fund formations. The firm is especially renowned in North Asia, and noted for its India-related work and for strength in Malaysia. It is further recommended for US-Asia deals, handling work involving clients in the TMT and life sciences sectors.

Strengths

"Their wealth of experience and expertise in handling complex and sophisticated corporate matters was truly impressive. They certainly stood out for their exemplary engagement throughout the negotiation process."

"Cleary demonstrated they are very strong when it comes to handling complex and sophisticated matters."

Work highlights

Cleary Gottlieb Steen & Hamilton represented Palantir Technologies in connection with the establishment of a joint venture with HD Hyundai for commercialising Palantir's proprietary software platforms in Korea.

Cleary Gottlieb Steen & Hamilton advised DCP Capital on a minority and PIPE investment into the Chinese operations of Jamieson Wellness.

Cleary Gottlieb Steen & Hamilton advised Sequoia Capital China on its acquisition of a 62.5% equity interest in Rare, a Korean fashion concept store.

Notable practitioners

Sang Jin Han is a key contact for the South Korea practice. Denise Shiu is a key contact in the Beijing office, while Freeman Chan is a key contact in the Hong Kong office.